NASDAQ: PRENW - Prenetics Holding Company Limited

Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0.00%

Cronograma de promoção Prenetics Holding Company Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Prenetics Holding Company Limited

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests.

mais detalhes
Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. It operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2022-05-18
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 0.0104
Alteração de preço por dia: 0% (0.0108)
Alteração de preço por semana: +11.34% (0.0097)
Alteração de preço por mês: -22.3% (0.0139)
Alteração de preço em 3 meses: +9.09% (0.0099)
Mudança de preço em seis meses: 0% (0.0108)
Mudança de preço por ano: +47.95% (0.0073)
Mudança de preço desde o início do ano: -0.9174% (0.0109)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Eficiência

Nome Significado Nota
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA 0 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 135.49 10
Rentabilidade Ebitda, % 158.67 10
Rentabilidade EPS, % 104.33 10
Total: 10
Mais detalhes

Supervisor Cargo Pagamento Ano de nascimento
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO 1979 (46 anos)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer 1974 (51 ano)
Mr. Hoi Chun Lo Chief Financial Officer 1985 (40 anos)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Yung Ho Wong DPHIL Chief Technology Officer 1982 (43 ano)
Dr. Senthil Sundaram M.D. Chief Clinical Officer 1974 (51 ano)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA 1984 (41 ano)
Mr. Walt Ling Chief Executive Officer of ACT Genomics

Endereço: Hong Kong, Quarry Bay, Unit 703-706 K11 Atelier King’s Road - abrir no Google Maps, abrir mapas Yandex
Site: https://www.prenetics.com